Defining the role of PIM kinases in hypoxia-induced prostate cancer invasion
Defining the role of PIM kinases in hypoxia-induced prostate cancer invasion
批准号:
10557063
负责人:
Corbin C Jensen
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-29 至 2023-01-30
关键词:
3-DimensionalActinsAmericanAntimetastatic AgentAutomobile DrivingBiochemicalBiologicalBladderCancer EtiologyCancer PatientCellsCessation of lifeClinicClinicalCoculture TechniquesComplexCytoskeletonDataDetectionDiseaseDisease ProgressionDistantDropsDrug TargetingEncapsulatedGeneticGlandGoalsGrantHypoxiaIn VitroIndolentInvadedKnowledgeLinkMalignant neoplasm of prostateMediatingMediatorMetastasis InductionModelingMuscleNatureNeoplasm MetastasisOxygenPIM1 genePathway interactionsPatient CarePatientsPhenotypePhosphorylationPhosphorylation SitePhysiologicalPolymersPreventionProgression-Free SurvivalsProstateProteinsRegulationResearchResearch ProposalsRoleSignal PathwaySignal TransductionSiteSite-Directed MutagenesisSmooth MuscleSurvival RateTestingTherapeuticTranslationsTreatment EfficacyTumor Cell InvasionTumor PromotionUp-RegulationWorkbasecancer cellcancer diagnosiscell motilityclinically relevanthuman diseasehypoxia inducible factor 1improvedin vivoin vivo Modelinhibitorinnovationinsightlive cell imagingmalemenmetastatic processmortalityneoplastic cellnovelphosphoproteomicspolymerizationpre-clinicalpredictive markerpreventprostate cancer metastasisprostate cancer modelprostate cancer preventionprostate cancer progressionproto-oncogene protein pimtherapeutically effectivetreatment strategytumortumor growthtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The prevention of invasion and metastasis remains paramount for the reduction of prostate cancer mortality.
Locally confined tumors are rarely lethal and survival is all but assured until metastasis occur, thus
understanding the mechanisms driving invasion are critical. Once possible driver is hypoxia, or low
oxygenation. We do not know the biological mechanisms by which hypoxia drives metastasis and currently
have no effective therapeutic options to prevent it. However, in this research proposal, we have reason to
believe that hypoxia-induced PIM is leading to increased invasion and metastasis through regulation of Abi2
and actin polymerization. To test this hypothesis, we will determine how hypoxia modulates Abi2 levels and
WRC formation. To do this we will investigate the effects of hypoxia-induced PIM phosphorylation on Abi2,
determine effects of hypoxia and PIM on the WRC, and characterize the effect of hypoxia on actin dynamics.
Additionally, we will investigate the role of PIM in hypoxia-induced invasion. The goal is to determine whether
hypoxia-induced PIM is sufficient to drive invasion in vitro and understand the role of PIM in determining
invasive potential of cells in vivo. These data should help in establishing a novel connection between PIM
kinases and regulation of cell motility via cytoskeletal rearrangement in hypoxia. Elucidating mechanisms
regulating motility and invasion are critical for understanding metastatic disease progression. In doing this
project, we will establish a novel prostate-specific invasion model to better recapitulate what occurs in human
disease. This will allow for better clarity into the metastatic process and ultimately should provide insight into
how to improve overall patient survival. These results will elucidate the potential therapeutic role for PIM
inhibitors and how they could be used to increase the efficacy of patient treatment. Lastly these data will also
yield insight into mechanisms of how hypoxia increases invasion that could be exploited in the clinic and
make a direct impact on patients care. In summary, the research proposed in the grant will elucidate
mechanisms by which hypoxia is a driving factor in metastasis and provide insight into pathways that serve
as viable drug targets to improve efficacy of patient treatment while simultaneously increasing overall patient
survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the role of PIM kinases in hypoxia-induced prostate cancer invasion
-
批准号:10229919
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2022
-
负责人:Corbin C Jensen
-
依托单位:
海外基金